{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-085380","form_type":"8-K","ticker":"DSGN","cik":"0001807120","company_name":"Design Therapeutics, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.805628+00:00","generated_at":"2026-05-19T11:05:05.543013+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Design Therapeutics stockholders elect directors and ratify auditor at 2025 annual meeting","bullets":["Heather Berger, Ph.D., Rodney Lappe, Ph.D., and John Schmid elected as Class I directors to serve until 2028 annual meeting.","Rodney Lappe received 32,799,677 votes for, 9,948,461 withheld, indicating notable opposition.","Ernst & Young LLP ratified as independent auditor for FY2025 with 53,577,053 votes for, 2,731 against, 1,795 abstentions.","A total of 56,768,678 shares were outstanding and entitled to vote as of the April 15, 2025 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-085380","json":"https://secwatch.observer/filing/0000950170-25-085380.json","markdown":"https://secwatch.observer/filing/0000950170-25-085380.md","text":"https://secwatch.observer/filing/0000950170-25-085380.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1807120/000095017025085380/0000950170-25-085380-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1807120/000095017025085380/dsgn-20250610.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T11:05:05.543013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}